Board MeetingJul 22, 2026, 05:11 PM
Supernus Pharmaceuticals Q2 2026 Earnings Call Set for Aug 4
AI Summary
Supernus Pharmaceuticals, Inc. announced it will report its second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026. The company will host a conference call and webcast on the same day at 4:30 p.m. E.T. to discuss these results. CEO Jack Khattar and CFO Tim Dec will lead the discussion, with a replay available on the company's investor relations website.
Key Highlights
- Supernus Pharmaceuticals will report Q2 2026 financial results after market close on August 4, 2026.
- A conference call and webcast will be held on August 4, 2026, at 4:30 p.m. E.T.
- CEO Jack Khattar and CFO Tim Dec will host the conference call.
- The webcast will be accessible on the company's Investor Relations website.
- A replay of the call will be available on the website for 60 days.
Price Impact
More from SUPN